JP2024540237A5 - - Google Patents

Info

Publication number
JP2024540237A5
JP2024540237A5 JP2024525919A JP2024525919A JP2024540237A5 JP 2024540237 A5 JP2024540237 A5 JP 2024540237A5 JP 2024525919 A JP2024525919 A JP 2024525919A JP 2024525919 A JP2024525919 A JP 2024525919A JP 2024540237 A5 JP2024540237 A5 JP 2024540237A5
Authority
JP
Japan
Prior art keywords
cells
cell
derived
receptor
car
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2024525919A
Other languages
English (en)
Japanese (ja)
Other versions
JP2024540237A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2022/079412 external-priority patent/WO2023081896A1/en
Publication of JP2024540237A publication Critical patent/JP2024540237A/ja
Publication of JP2024540237A5 publication Critical patent/JP2024540237A5/ja
Pending legal-status Critical Current

Links

JP2024525919A 2021-11-08 2022-11-07 固形腫瘍における同種異系細胞療法の輸送のための操作されたエフェクター細胞 Pending JP2024540237A (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US202163277034P 2021-11-08 2021-11-08
US63/277,034 2021-11-08
US202263329203P 2022-04-08 2022-04-08
US63/329,203 2022-04-08
PCT/US2022/079412 WO2023081896A1 (en) 2021-11-08 2022-11-07 Engineered effector cells for trafficking of allogeneic cell therapies in solid tumors

Publications (2)

Publication Number Publication Date
JP2024540237A JP2024540237A (ja) 2024-10-31
JP2024540237A5 true JP2024540237A5 (OSRAM) 2025-11-12

Family

ID=86242252

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2024525919A Pending JP2024540237A (ja) 2021-11-08 2022-11-07 固形腫瘍における同種異系細胞療法の輸送のための操作されたエフェクター細胞

Country Status (8)

Country Link
US (1) US20250009882A1 (OSRAM)
EP (1) EP4430165A4 (OSRAM)
JP (1) JP2024540237A (OSRAM)
KR (1) KR20240099409A (OSRAM)
AU (1) AU2022382406A1 (OSRAM)
CA (1) CA3236260A1 (OSRAM)
IL (1) IL312565A (OSRAM)
WO (1) WO2023081896A1 (OSRAM)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN117343908B (zh) * 2023-12-05 2024-02-09 南京大学 一种通过真菌精准激活的car-t细胞、制备方法、应用及药物组合物

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BR112020010597A2 (pt) * 2017-12-08 2020-10-27 Fate Therapeutics, Inc. imunoterapias com o uso de células efetoras derivadas de ipsc intensificadas
WO2019194549A1 (ko) * 2018-04-02 2019-10-10 고려대학교 산학협력단 체세포에서 유도 만능 줄기세포로의 역분화 유도용 조성물 및 이를 이용한 역분화 유도방법
CA3146967A1 (en) * 2019-07-17 2021-01-21 Fate Therapeutics, Inc. Immune effector cell engineering and use thereof
KR20250005097A (ko) * 2022-04-08 2025-01-09 페이트 세러퓨틱스, 인코포레이티드 고형 종양 표적화 골격을 갖는 세포 및 이의 용도

Similar Documents

Publication Publication Date Title
JP2022541441A5 (OSRAM)
JP2022548943A5 (OSRAM)
JP2022510207A5 (OSRAM)
JP2023505206A5 (OSRAM)
JP2021505131A5 (OSRAM)
JP2022550899A5 (OSRAM)
JP2023548467A5 (OSRAM)
Maher Immunotherapy of malignant disease using chimeric antigen receptor engrafted T cells
KR102608966B1 (ko) 세포 치료요법을 위한 항상성 활성 사이토킨 수용체
JP2023548829A5 (OSRAM)
ES2692206T3 (es) Inmunoterapia combinada de receptores de reconocimiento de antígenos y células hematopoyéticas para el tratamiento de enfermedades
JP2023530704A5 (OSRAM)
ES2867224T3 (es) Etiquetas genéticas transgénicas y métodos de uso
Thakur et al. Cancer therapy with bispecific antibodies: Clinical experience
US20230210905A1 (en) T cell-antigen coupler with various construct optimizations
JP2023545992A5 (OSRAM)
CN105339498A (zh) 癌症中靶向cd138
JP7319250B2 (ja) Ｓｔｒｅｐ－タグ特異的結合タンパク質およびその使用
JP7701453B2 (ja) 固形腫瘍標的化骨格を有する細胞及びその使用
JP2025105605A5 (OSRAM)
JP2024515920A5 (OSRAM)
JP2024526237A5 (OSRAM)
KR20220003041A (ko) 조합 치료법
JP2024543024A5 (OSRAM)
JP2024531910A5 (OSRAM)